University of?Maryland's?Institute for Bioscience and Biotechnology Research (IBBR)?has been awarded a?$6.0 million?grant entitled, "Structure-Based Vaccine Design for Hepatitis C Virus," to develop a novel prophylactic vaccine to prevent hepatitis C viru